Careview Communications, Inc. 8-K 


Exhibit 10.53


 





TENTH
AMENDMENT TO

NOTE AND WARRANT PURCHASE AGREEMENT


This TENTH AMENDMENT
TO NOTE AND WARRANT PURCHASE AGREEMENT, dated as of July 13, 2018 (this “Amendment”), is made by and among
CAREVIEW COMMUNICATIONS, INC., a Nevada corporation (the “Company”), the HealthCor Parties and the Investors
(each as defined below), as holders of a majority of the shares of Common Stock issued or issuable (on an as converted basis) upon
conversion of the Notes and Warrants (collectively, the “Majority Investors”), and such of the Existing Investors
(as defined below) who are identified as investors on Annex I attached hereto (the “Investors”).


WITNESSETH:


WHEREAS,
the Company, HealthCor Partners Fund, L.P. (“HealthCor Partners”), HealthCor Hybrid Offshore Master Fund, L.P.
(“HealthCor Hybrid” and, together with HealthCor Partners, the “HealthCor Parties”) and certain
additional investors that purchased additional Notes and additional Warrants on February 17, 2015 (the “2015 Investors”)
and on February 23, 2018 (the “February 2018 Investors” and, together with the 2015 Investors and the HealthCor
Parties, the “Existing Investors”) are parties to that certain Note and Warrant Purchase Agreement, dated as
of April 21, 2011 (as amended from time to time, including without limitation pursuant to that certain Note and Warrant Amendment
Agreement dated December 30, 2011, that certain Second Amendment to Note and Warrant Purchase Agreement dated January 31, 2012,
that certain Third Amendment to Note and Warrant Purchase Agreement dated August 20, 2013, that certain Fourth Amendment to Note
and Warrant Purchase Agreement dated January 16, 2014, that certain Fifth Amendment to Note and Warrant Purchase Agreement dated
December 15, 2014, that certain Sixth Amendment to Note and Warrant Purchase Agreement dated March 31, 2015, that certain Seventh
Amendment to Note and Warrant Purchase Agreement dated June 26, 2015, that certain Eighth Amendment to Note and Warrant Purchase
Agreement dated February 23, 2018 and that certain Ninth Amendment to Note and Warrant Purchase Agreement dated July 10, 2018,
the “Purchase Agreement”);


WHEREAS, as
contemplated by the Purchase Agreement, the Company issued and sold (a) $20,000,000 initial principal amount of Notes (the
“2011 Notes”) and Warrants to purchase 11,782,859 shares of Common Stock (the “2011 Warrants”)
to the HealthCor Parties on April 21, 2011, (b) $5,000,000 initial principal amount of Supplemental Closing Notes (the
“2012 Notes”) to the HealthCor Parties on January 31, 2012, (c) $5,000,000 initial principal amount of
2014 Supplemental Closing Notes and 2014 Supplemental Warrants to purchase 4,000,000 shares of Common Stock to the HealthCor Parties
on January 16, 2014, (d) $6,000,000 initial principal amount of Fifth Amendment Supplemental Closing Notes and Fifth Amendment
Supplemental Warrants to purchase 3,692,308 shares of Common Stock to HealthCor Partners and the 2015 Investors on February 17,
2015 and (e) $2,050,000 initial principal amount of Eighth Amendment Supplemental Notes and Eighth Amendment Supplemental
Warrants to purchase 512,500 shares of Common Stock to the February 2018 Investors on February 23, 2018;


WHEREAS,
pursuant to Section 7.9 of the Purchase Agreement and subject to the terms and conditions contained herein, the parties hereto
desire to amend the Purchase Agreement as set forth herein for the purposes of, among other things, providing for an additional
investment in the Company by the Investors;






    	 	1	 



    	 



    

 


WHEREAS,
the Investors wish to purchase from the Company, and the Company wishes to sell and issue to the Investors, upon the terms and
conditions stated herein and in the Purchase Agreement, additional Notes in the initial aggregate principal amount of $1,000,000,
with a conversion price per share equal to $0.05 (subject to adjustment as described therein) (the “Tenth Amendment Supplemental
Closing Notes”) on the later of July 13, 2018 or the satisfaction of the closing conditions outlined herein (the
“Tenth Amendment Supplemental Closing Date”); and


WHEREAS,
the Company and the Investors are executing and delivering this Amendment in reliance upon the exemption from securities registration
afforded by the provisions of Regulation D, as promulgated by the Commission under the Act.


NOW, THEREFORE,
in consideration of the mutual promises, representations, warranties and covenants contained herein and in the Purchase Agreement,
which represent integral components of the transactions contemplated hereby and thereby and shall be fully enforceable by the parties
hereto, and for other good and valuable consideration, the receipt and sufficiency of which hereby acknowledged, the Company, the
Majority Investors and the Investors mutually agree as follows:


1.                 
Definitions. Capitalized terms used in this Amendment but not defined in this Amendment shall have the meanings ascribed
to them in the Purchase Agreement.


2.                 
Amendment to Purchase Agreement. Section 1.3 of the Purchase Agreement is hereby amended and restated in its entirety
to read as follows:


“Sale of Additional
Securities. After the Closing, the Company may sell to the Investors, on the same terms and conditions as those contained in
this Agreement (as amended from time to time), up to $19,050,000 in additional Notes and Warrants to purchase an additional 8,204,808
shares of Common Stock, and (a) any such additional Notes shall be included within the definition of “Notes” under
this Agreement; (b) any such additional Warrants shall be included within the definition of “Warrants” under this Agreement;
(c) any such additional Notes and additional Warrants shall be included within the definition of “Closing Securities”
under this Agreement; (d) any shares of Common Stock issuable upon conversion of any such additional Notes shall be included within
the definition of “Note Shares” under this Agreement; (e) any shares of Common Stock issuable upon the exercise of
any such additional Warrants shall be included within the definition of “Warrant Shares” under this Agreement; and
(f) any amendment or joinder to this Agreement, the Notes, the Warrants, the Security Agreement, the IP Security Agreement, the
Registration Rights Agreement, the PDL Subordination Agreement, the PDL Credit Agreement or any other documents contemplated or
necessitated hereby in order to further consummate the sale of any such additional Notes and/or additional Warrants shall be included
within the definition of “Transaction Documents” under this Agreement. Any such additional Notes shall be substantially
in the form of the senior secured convertible note attached hereto as Exhibit A, with such updates to the “Issuance
Date”, “Maturity Date”, “First Five Year Note Period”, “Conversion Price” and other terms
as shall be mutually acceptable to the Company and the Investors. Any such additional Warrants shall be substantially in the form
of common stock warrant attached hereto attached hereto as Exhibit B, with such updates to the “Expiration Date”,
“Warrant Price” and other terms as shall be mutually acceptable to the Company and the Investors.”






    	 	2	 



    	 



    




3.                 
Issuance of Tenth Amendment Supplemental Closing Notes. Subject to the terms and conditions of this Amendment and
the Purchase Agreement, on the Tenth Amendment Supplemental Closing Date, each of the Investors listed on Annex I shall
severally, and not jointly, purchase from the Company, and the Company shall sell and issue to each Investor, the Tenth Amendment
Supplemental Closing Notes in the respective amounts set forth opposite each such Investor’s name on Annex I in exchange
for a cash payment by each such Investor of the amount set forth opposite such Investor’s name on Annex I (the “Tenth
Amendment Supplemental Purchase Price”). The Tenth Amendment Supplemental Closing Notes shall be substantially in the
form attached hereto as Exhibit A-1. The closing of the purchase, sale and issuance of the Tenth Amendment Supplemental
Closing Notes (the “Tenth Amendment Supplemental Closing”) shall take place on the Tenth Amendment Supplemental
Closing Date at the offices of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC, One Financial Center, Boston, MA 02111, or at
such other location as the Company and the Investors shall mutually agree. At the Tenth Amendment Supplemental Closing, the Company
shall have satisfied the closing conditions set forth in subsections (c)-(h), (k) and (l) of Section 4.1 of the Purchase Agreement
as of the Tenth Amendment Supplemental Closing Date (for avoidance of doubt, reading references to the “Closing Date”
in such subsections to refer to the Tenth Amendment Supplemental Closing Date) and shall deliver to the Investors the Tenth Amendment
Supplemental Closing Notes, each registered in such name or names as the Investors may designate. On the Tenth Amendment Supplemental
Closing Date, the Investors shall deliver their respective portion of the Tenth Amendment Supplemental Purchase Price to the Company,
payable by wire transfer in same day funds to an account specified by the Company in writing. The Tenth Amendment Supplemental
Closing Notes shall be secured as and to the same extent as the other Notes issued pursuant to the Purchase Agreement, as described
in the Transaction Documents, including, without limitation, the Security Agreement and IP Security Agreement.


4.                 
Condition Precedent. The Tenth Amendment Supplemental Closing shall be further conditioned upon the execution and
delivery, as of the Tenth Amendment Supplemental Closing, by the Company, CareView Texas and PDL of the Third Amendment to Credit
Agreement, in the form attached as Exhibit B hereto.


5.                 
Bringdown of Company’s Representations and Warranties. The Company represents and warrants to the Investors
that, except as set forth in a disclosure letter delivered to the Investors as of the Tenth Amendment Supplemental Closing Date,
the statements contained in Article 2 and the first sentence of Section 5.1(k) of the Purchase Agreement are
true and correct as of the Tenth Amendment Supplemental Closing Date as though made as of such date, except to the extent such
representations and warranties are specifically made as of a particular date (in which case such representations and warranties
are true and correct as of such other specified date). For the avoidance of doubt, as a result of the operation of this Section 5
and for purposes hereof, any representation and warranty made in the Purchase Agreement “as of the Closing Date” shall
be deemed to be made as of the Tenth Amendment Supplemental Closing Date, any reference in a representation and warranty to “the
date hereof” shall be deemed to refer to the date of this Amendment, any retroactive time period set forth in a representation
and warranty shall be deemed to be retroactive from the date of this Amendment for such time period, and any reference to “Closing
Securities” shall be deemed to refer to the Tenth Amendment Supplemental Closing Notes.






    	 	3	 



    	 



    




6.                 
Bringdown of Investors’ Representations and Warranties. Each Investor, severally and not jointly, represents
and warrants to the Company that the statements contained in Article 3 of the Purchase Agreement are true and correct
as of the Tenth Amendment Supplemental Closing Date as though made as of the Tenth Amendment Supplemental Closing Date (for this
purpose, reading any reference to “Closing Securities” in such Article 3 to refer only to the Tenth Amendment
Supplemental Closing Notes).


7.                 
Form D and Blue Sky. The Company agrees to file a Form D with respect to the Tenth Amendment Supplemental
Closing Notes as required under Regulation D and to provide a copy thereof to the Investors promptly after such filing. The
Company shall take such action as is necessary in order to obtain an exemption for or to qualify the Tenth Amendment Supplemental
Closing Notes for sale to the Investors at the Tenth Amendment Supplemental Closing pursuant to this Amendment under applicable
securities or “Blue Sky” laws of the states of the United States, and shall provide evidence of any such exemption
or qualification so taken to the Investors on or prior to the Tenth Amendment Supplemental Closing Date promptly upon the request
of any Investor.


8.                 
Acknowledgement and Undertaking by Company. The Company agrees and acknowledges that the transactions described in
this Amendment and the issuance of the Tenth Amendment Supplemental Closing Notes and shares of Common Stock upon exercise or conversion
of the Tenth Amendment Supplemental Closing Notes are intended to be exempt from Section 16(b) of the Exchange Act to the maximum
extent permitted by law including pursuant to Rule 16b-3 under the Exchange Act and the Commission’s releases and interpretations,
and will, or will cause its successors and assigns to, from time to time as and when requested by the Investors, execute and deliver,
or cause to be executed and delivered, to the extent it may lawfully do so, all such documents and instruments and take, or cause
to be taken, to the extent it may lawfully do so, all such further actions as the Investors may reasonably deem necessary and desirable
to facilitate and effect any such exemption. 


9.                 
No Further Amendments. Except as amended by this Amendment, the Purchase Agreement shall remain in full force and
effect in accordance with its terms.






    	 	4	 



    	 



    




10.             
Miscellaneous.


(a)              
Ratification and Confirmation. The Company acknowledges, agrees and confirms that: (x) the Purchase Agreement and
each of the other Transaction Documents, as amended and otherwise modified by the amendments and other modifications specifically
provided herein or contemplated hereby, are and shall continue to be in full force and effect and are hereby in all respects ratified
and confirmed; and (y) without limiting the generality of the foregoing clause (x), (i) all obligations, liabilities and Indebtedness
of the Company under the Transaction Documents, as amended hereby, constitute “Obligations” (as defined in the Security
Agreement) secured by and entitled to the benefits of the security set forth in the Security Agreement and the IP Security Agreement,
and the liens and security interests granted in favor of the Investors under the terms of the Security Agreement and the IP Security
Agreement are and remain perfected, effective, enforceable and valid and such liens and security interests are, in each case, a
first priority lien and security interest (except to the extent otherwise expressly permitted by the Transaction Documents) and
such liens and security interests are hereby in all respects ratified and confirmed, and (ii) the shares of Common Stock issuable
upon exercise or conversion of the Tenth Supplemental Closing Notes shall constitute “Registrable Securities” under
the Registration Rights Agreement.


(b)              
Expenses. The Company will pay and bear full responsibility for the reasonable legal fees and other out-of-pocket
costs and expenses of the Investors attributable to the negotiation and consummation of the transactions contemplated hereby.


(c)              
Further Assurances. The Company shall duly execute and deliver, or cause to be duly executed and delivered, at its
own cost and expense, such further instruments and documents and to take all such action, in each case as may be necessary or proper
in the reasonable judgment of the Investors to carry out the provisions and purposes of this Amendment.


(d)              
Survival. The representations, warranties, covenants and agreements made herein shall survive any investigation made
by any party hereto, the execution and delivery of this Amendment and the closing of the transactions contemplated hereby.


(e)              
Governing Law. All questions concerning the construction, interpretation and validity of this Amendment shall be
governed by and construed and enforced in accordance with the domestic laws of the State of Delaware without giving effect to any
choice or conflict of law provision or rule (whether in the State of Delaware or any other jurisdiction) that would cause the application
of the laws of any jurisdiction other than the State of Delaware. In furtherance of the foregoing, the internal law of the State
of Delaware will control the interpretation and construction of this Amendment, even if under such jurisdiction’s choice
of law or conflict of law analysis, the substantive law of some other jurisdiction would ordinarily or necessarily apply.


(f)               
Construction. The Company and the Investors acknowledge that the Company and its independent counsel and the Investors
and their independent counsel have jointly reviewed and drafted this document, and agree that any rule of construction and interpretation
to the effect that drafting ambiguities are to be resolved against the drafting party shall not be employed.






    	 	5	 



    	 



    




(g)              
Counterparts; Facsimile and Electronic Signatures. This Amendment may be executed in any number of counterparts,
and each such counterpart hereof shall be deemed to be an original instrument, but all such counterparts together shall constitute
but one agreement. Counterpart signatures to this Amendment delivered by facsimile or other electronic transmission shall be acceptable
and binding.


(h)              
Headings. The section and paragraph headings contained in this Amendment are for reference purposes only and shall
not affect in any way the meaning or interpretation of this Amendment.


[Signature Pages Follow]






    	 	6	 



    	 



    




IN WITNESS WHEREOF,
each of the undersigned has duly executed this Tenth Amendment to Note and Warrant Purchase Agreement as of the date first written
above.


 


	 	COMPANY:
	 	 	 
	 	CareView Communications, Inc., a Nevada corporation
	 	 	 
	 	By:	/s/ Steven G. Johnson
	 	 	Name: Steven G. Johnson
	 	 	Title: President


 


 


[Signature Page to Tenth Amendment to Note and Warrant Purchase Agreement]






    	 



    	 



    

 


 


	 	MAJORITY INVESTORS:
	 	 	 
	 	HealthCor Partners Fund, L.P.
	 	By: HealthCor Partners Management L.P., as Manager
	 	By: HealthCor Partners Management, G.P., LLC, as General Partner
	 	 	 
	 	By:	/s/ Jeffrey C. Lightcap
	 	Name: Jeffrey C. Lightcap
	 	Title: Senior Managing Director
	 	Address:	HealthCor Partners
	 	 	1325 Avenue of Americas, 27th Floor
	 	 	New York, NY 10019
	 	 	 
	 	 
	 	HealthCor Hybrid Offshore Master Fund, L.P.
	 	By: HealthCor Hybrid Offshore G.P., LLC, as General Partner
	 	 	 
	 	By:	/s/ Joseph P. Healey
	 	Name: Joseph P. Healey
	 	Title: Trustee
	 	Address:	HealthCor Partners
	 	 	1325 Avenue of Americas, 27th Floor
	 	 	New York, NY 10019
	 	 
	 	 
	 	 	 	 


 


[Signature Page to Tenth Amendment to Note and Warrant Purchase Agreement]



    	 



    	 



    

 


	 	
        MAJORITY INVESTORS 

        AND INVESTORS:

	 	 
	 	 
	 	/s/ Steven B. Epstein
	 	Steven B. Epstein
	 	 
	 	 
	 	/s/ Dr. James R. Higgins
	 	Dr. James R. Higgins
	 	 
	 	 
	 	/s/ Steven G. Johnson
	 	Steven G. Johnson
	 	 
	 	 
	 	/s/ Jeffrey C. Lightcap
	 	Jeffrey C. Lightcap
	 	 


 


 


[Signature Page to Tenth Amendment to Note and Warrant Purchase Agreement]



    	 



    	 



    

 


 


ACKNOWLEDGED AND AGREED:


 


	CareView Communications, Inc., a Texas corporation	 
	 	 	 
	By:	/s/ Steven G. Johnson	 
	Name: 	Steven G. Johnson	 
	Title: 	President	 
	 	 	 
	 	 	 
	CareView Operations, LLC	 
	 	 	 
	By:	/s/ Steven G. Johnson	 
	Name: 	Steven G. Johnson	 
	Title: 	President	 


 


 


 


[Signature Page to Tenth Amendment to Note and Warrant Purchase Agreement]



    	 



    	 



    




 


 


Annex I


 


Tenth Amendment Supplemental Closing Note
Investors


 


	Investor	Tenth Amendment

Supplemental Closing Notes	Tenth Amendment

Supplemental Warrants	Tenth Amendment

Supplemental Purchase Price
	Steven B. Epstein	$50,000	—	$50,000
	Dr. James R. Higgins	$200,000	—	$200,000
	Steven G. Johnson	$500,000	—	$500,000
	Jeffrey C. Lightcap	$250,000	—	$250,000
	TOTAL	$1,000,000	N/A	$1,000,000


 


 






    	 



    	 



    

  


Exhibit A-1


 


Form of Tenth Amendment Supplemental Closing
Notes


 


(attached)


 


 






    	 



    	 



    




 


Exhibit B


 


Form of Third Amendment to Credit Agreement


 


(attached)